S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AUPH Aurinia Pharmaceuticals Inc

9.03

-0.01 (-0.11%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Aurinia Pharmaceuticals Charts.

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Aurinia Pharmaceuticals Charts.

Aurinia Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Tuesday 19 November 2024 (1 month ago) • Business Wire

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024
Friday 15 November 2024 (1 month ago) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Aurinia to Participate in Jefferies London Healthcare Conference
Thursday 14 November 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth
Thursday 7 November 2024 (2 months ago) • Business Wire

More Aurinia Pharmaceuticals Inc News Articles

Invesco QQQ Trust Series 1

AUD vs US Dollar

S&P ASX 300 Metals and M...

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions